* Molecular Templates Inc MTEM.OQ MTEM.O is expected
to show a
fall in quarterly revenue when it reports results on March 27
(estimated).
* The Austin Texas-based company is expected to report a
50.9% decrease in revenue to $8.812 million from $17.96 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Molecular Templates
Inc
is for a loss of 30 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Molecular
Templates Inc is $10.5, above its last closing price of $0.34.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.48 -0.48 -0.44 Beat 8
Jun. 30 2022 -0.45 -0.48 -0.44 Beat 8.5
Mar. 31 2022 -0.45 -0.47 -0.38 Beat 19.6
Dec. 31 2021 0.10 -0.40 -0.18 Beat 54.7
Sep. -0.38 -0.38 -0.54 Missed -43
30 2021
Jun. 30 2021 -0.24 -0.27 -0.28 Missed -1.8
Mar. 31 2021 0.19 0.14 -0.51 Missed -454.8
Dec. 31 2020 -0.47 -0.42 -0.53 Missed -26.3
This summary was machine generated March 24 at 22:36 GMT. All
figures in US dollars unless otherwise stated